Loccus
- Company typePrivate
- Founded2002
- HeadquartersCotia, Brazil
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Loccus does
Loccus do Brasil Ltda is a privately held Brazilian biotechnology manufacturer founded in 2002 and headquartered in Cotia, São Paulo (CNPJ 05.094.718/0001-08), specializing in laboratory equipment, reagents, and consumables for molecular biology and life sciences applications. The company builds a vertically integrated portfolio centered on two proprietary technology platforms: the Extracta® line of automated nucleic acid extraction systems using silica-coated magnetic microparticle technology (including the Extracta Station 9600, 4800, and the newer integrated Amplio Station 6400), and the Amplio® line of real-time PCR/qPCR instruments (Amplio 96, portable Amplio 16, AmpliGene thermocyclers). Supporting products include MasterMix reagents with hot-start Taq polymerase and UDG/UNG contamination control, fluorimeters (FluorQuant), microvolume spectrophotometers (i-Quant), aseptic PCR workstations (DNA Workstation), and consumables (PCR plates, optical seals, microtubes). Several MasterMix and Extracta Kit products hold ANVISA in-vitro diagnostic (IVD) registrations for the Brazilian clinical diagnostics market, and the integrated systems support HL7 LIS connectivity with barcode scanning.
Loccus generates revenue through direct sales of capital equipment, one-time reagent and consumable purchases, and recurring IVD reagent sales, with pricing denominated in Brazilian Real via a quote-based system starting from approximately R$10,000 for the Extracta Station 4800. Go-to-market is sales-led: regional sales representatives cover all Brazilian states (Sudeste, Centro-Oeste, Sul, Norte, Nordeste), and the company has extended into Colombia, Ecuador, Bolivia, and Peru via local distribution partners (Suministros Clínicos ISLA SAS, GenLife, ACTILAB, and Umbrella Genomics respectively). Customer segments are diversified across research laboratories, human clinical diagnostics, veterinary/animal health, and precision agriculture. The company operates a digital storefront at loccus.com.br with downloadable catalogs and product documentation, maintains LGPD-compliant privacy practices, and has no disclosed venture capital or private equity backing, suggesting an organic, founder/family-owned growth profile.
Loccus firmographics
Firmographics- Name
- Loccus
- Legal name
- Loccus do Brasil Ltda
- Website
- https://loccus.com.br
- Company type
- Private
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Ownership category
- akta.pro rank
Loccus industry classification
Industry- Product category
- Molecular Biology Laboratory Equipment
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516), In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- Laboratory Analytical Instruments (3826), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF)
- akta.pro secondary industries
- Mass Spectrometry & Spectroscopy Instruments (HLAGAIAB), Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI), Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays) (HLAAALAL)
Keywords
Where Loccus is headquartered
LocationHeadquarters
- HQ city
- Cotia
- HQ country
- Brazil
- HQ region
- Latin America
Offices7 records
Markets served
Loccus business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations
Revenue model
- Laboratory Equipment Sales: Sale of automated extraction systems, PCR instruments, and related laboratory equipment. Products include Extracta stations, Amplio PCR systems, and thermocyclers.
- Reagent and Kit Sales: Sale of extraction and purification kits, MasterMix reagents, and specialty reagents for molecular biology applications. Includes IVD products with ANVISA registration.
- Consumables: Sale of PCR plates, tubes, seals, tips, and other laboratory consumables that complement the equipment and reagent lines.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Multi-year contract | Equipment pricing - Extracta Station 4800 |
| Unit Pricing | Multi-year contract | Equipment pricing - Amplio 16 Portable PCR |
| Other | Annual | Budget/Quote System |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
Loccus product offering
Product offeringCore offering
Loccus develops, manufactures, and distributes molecular biology laboratory equipment and reagents, including automated nucleic acid extraction systems (Extracta Station 9600/4800 and Extracta 16) using magnetic bead technology, real-time PCR detection systems (Amplio 96, Amplio 16 portable, Amplio Station 6400), Amplio MasterMix qPCR/RT-qPCR reagents, thermocyclers, and consumables. Products serve research laboratories, human clinical diagnostics labs (with ANVISA-registered IVD products), veterinary diagnostic labs, and precision agriculture testing facilities across Brazil and selected Latin American markets.
Product overview
Loccus is a Brazilian company (Loccus do Brasil Ltda) specializing in laboratory equipment, reagents, and consumables for life sciences and molecular biology. The product portfolio centers on automated nucleic acid extraction systems (Extracta Station series using magnetic bead technology) and real-time PCR solutions (Amplio series including Amplio 96, Amplio 16, and Amplio Station 6400 which combines extraction and qPCR). Key reagent products include Extracta Kit extraction reagents for DNA/RNA purification and Amplio MasterMix qPCR/RT-qPCR reagents with hot-start polymerase and UDG contamination control. Supporting equipment includes thermocyclers (AmpliGene Plus, TC600), aseptic workstations (DNA Workstation), fluorimeters (FluorQuant, i-Quant), and consumables (PCR plates, optical seals, microtubes). The Extracta Station automated systems integrate with Laboratory Information Systems (LIS) via HL7 protocol. All IVD products hold ANVISA registration numbers.
Differentiator
Problem solved
Functional benefit
Brands
- Extracta: Automatic DNA and RNA extractor product line
- Amplio
- Amplio MasterMix
- i-Quant
- FluorQuant
- AmpliGene
- Extracta Station
Products and services
- Extracta Station 9600
Quantifiable outcome
- Extraction and PCR setup of 96 samples in 90 minutes with Extracta Station 9600
- +3 more outcomes
Companies that use Loccus
Customer profileSegments4 records
Ideal customer profiles2 records
Loccus technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
Feature7 records
Loccus partnerships and signals
Strategic signalScale indicators2 records
Recent moves6 records
Expansion highlights5 records
Loccus competitors and assessment
Company assessmentDirect peers
- Bio-Rad Laboratories: Global leader in qPCR instrumentation (CFX series), sample preparation reagents, and IVD products. Directly comparable to Loccus's Amplio qPCR systems, Extracta extraction kits, and Amplio MasterMix reagents across the same customer segments.
- Analytik Jena: Specialist in PCR/qPCR instrumentation (qTOWER series), automated nucleic acid extraction (InnuPure), and IVD reagents. Closely comparable mid-tier instrument + reagent vendor with similar workflow-integration story to Loccus.
- Promega Corporation: Privately held molecular biology reagents and sample-prep supplier offering Maxwell automated extraction systems and PCR reagents. Closely comparable to Loccus's reagent + instrument consumables playbook in research and clinical diagnostics.
- Qiagen: World-leading provider of nucleic acid extraction kits (QIAamp, QIAsymphony) and PCR enzymes/reagents with broad IVD footprint. Closely comparable to Loccus's magnetic-bead Extracta kits and automated extraction workstations in workflow integration and customer base.
- Hamilton Company: Manufacturer of automated liquid handling and sample-prep workstations (Microlab STAR, NIMBUS) including magnetic-bead nucleic acid extraction workflows. Comparable as another automation-focused mid-tier instrument competitor in molecular biology labs.
Broad incumbents
- Hologic: Global molecular diagnostics company (Panther system, Aptima assays) with strong women's health and infectious disease IVD menu. Comparable incumbent in clinical molecular diagnostics where Loccus competes with its IVD-registered extraction and qPCR reagents.
- Roche Diagnostics: Global leader in IVD molecular diagnostics (cobas systems) and PCR reagents with deep hospital and clinical lab penetration. Comparable as the dominant incumbent in the clinical diagnostics segment Loccus targets via its ANVISA-registered IVD reagents.
- Thermo Fisher Scientific: Largest global life-sciences tools company offering Applied Biosystems qPCR instruments, MagMAX extraction kits, and IVD molecular diagnostics reagents. Sits above Loccus as a broad incumbent whose installed base and global support set the competitive ceiling.
- Tecan: Provider of automated laboratory workstations (Freedom EVO, Fluent) and OEM components for molecular diagnostics workflows. Comparable as an incumbent in lab automation adjacent to Loccus's automated extraction and integrated platforms.
Emerging players
- New England Biolabs: Privately held molecular biology reagent specialist (enzymes, qPCR/LAMP master mixes, NEBNext NGS library prep) with a similarly reagent-anchored business model. Comparable as a reagent-side peer competing with Amplio MasterMix and supporting molecular biology workflows.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Loccus social profiles
Digital presenceLoccus compliance and trust
Trust signalCompliance7 records
Loccus financial estimates
Financial estimateRevenue estimate
Valuation estimate
Loccus leadership team
Management profileNumber of profiles
Loccus funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Loccus M&A and investment
M&A and investmentM&A
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Loccus
What does Loccus do?
Loccus develops, manufactures, and distributes molecular biology laboratory equipment and reagents, including automated nucleic acid extraction systems (Extracta Station 9600/4800 and Extracta 16) using magnetic bead technology, real-time PCR detection systems (Amplio 96, Amplio 16 portable, Amplio Station 6400), Amplio MasterMix qPCR/RT-qPCR reagents, thermocyclers, and consumables. Products serve research laboratories, human clinical diagnostics labs (with ANVISA-registered IVD products), veterinary diagnostic labs, and precision agriculture testing facilities across Brazil and selected Latin American markets.
Is Loccus a public or private company?
Loccus is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Loccus founded?
Loccus was founded in 2002. It employs 51 to 100 people.
Where is Loccus based?
Loccus is headquartered in Cotia, Brazil, in the Latin America region.
How does Loccus make money?
Three revenue lines are on record. Laboratory Equipment Sales are the primary driver. The others are reagent and Kit Sales and consumables.
Who are Loccus's main competitors?
Direct peers on record are Bio-Rad Laboratories, Analytik Jena, Promega Corporation, Qiagen and Hamilton Company. Broad incumbents are Hologic, Roche Diagnostics, Thermo Fisher Scientific and Tecan. New England Biolabs is listed as an emerging player.
Does Loccus have an API?
No public API is recorded for Loccus.
What industry is Loccus in?
Loccus's product category is Molecular Biology Laboratory Equipment. Its primary akta.pro industry code is HLAGAIAF, Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays), with a secondary code of HLAGAIAB, Mass Spectrometry & Spectroscopy Instruments. Its NAICS code is 334516 and its SIC code is 3826.